Can Austrian Lung Specialists' Assessments of Lung Cancer Screening be Influenced by a Fact Box?"
NCT ID: NCT04819477
Last Updated: 2024-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
973 participants
INTERVENTIONAL
2021-05-01
2021-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records
NCT06842056
Are Doctors Familiar With the Test Characteristics of Lung Cancer Screening?
NCT02542332
CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology
NCT03940846
Diagnostic Value of Bronchoscopic and Thoracoscopic Frozen Section Biopsies in Patients With Pleuropulmonary Tumors
NCT05385419
Virtual Intervention for Lung Cancer
NCT01684696
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A prerequisite for a detailed information of the patient about the implementation as well as the advantages and disadvantages of screening is that the physician has risk competence and knows and is able to interpret the screening data. The use of a fact box can be used to improve knowledge of statistical data.
In this prospective study with 1:1 randomized questioning using an Internet tool, physicians will be asked in 2 phases (before and after intervention with a fact box) about their assessment of the benefits and risks of lung cancer screening by thoracic computed tomography and about a potential intention to change referral behavior. Randomly assigned, half of the participants will receive the same information in addition to the fact box graphically presented as a Cates plot.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cate Plots
after being asked about current referral practices and assessment of benefits and risks of lung cancer screening, all respondents will receive the Fact box after which they will be randomized into two equal groups. The first group (Arm 1) receives a Cates plot and then another survey about assessment of benefits and risks of lung cancer screening and potential change in referral behavior.
Fact box
All physicians surveyed receive a fact box with numerical information on the benefits and harms of chest CT as a screening method.
In addition to the fact box, half of the participants will be randomly assigned to receive the same information in the form of a Cates plot.
Cates plot
In addition to the fact box, half of the participants will be randomly assigned to receive the same information in the form of a Cates plot.
Fact box only
after being asked about current referral practices and assessment of benefits and risks of lung cancer screening, all respondents will receive the Fact box after which they will be randomized into two equal groups. The second group (Arm 2) receives then a survey about assessment of benefits and risks of lung cancer screening and potential change in referral behavior
Fact box
All physicians surveyed receive a fact box with numerical information on the benefits and harms of chest CT as a screening method.
In addition to the fact box, half of the participants will be randomly assigned to receive the same information in the form of a Cates plot.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fact box
All physicians surveyed receive a fact box with numerical information on the benefits and harms of chest CT as a screening method.
In addition to the fact box, half of the participants will be randomly assigned to receive the same information in the form of a Cates plot.
Cates plot
In addition to the fact box, half of the participants will be randomly assigned to receive the same information in the form of a Cates plot.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karl Landsteiner Institute for Lung Research and Pneumological Oncology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Georg-Christian Funk, MD
Role: PRINCIPAL_INVESTIGATOR
2nd Medical Department with Pneumology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karl Landsteiner Institut für Lungenforschung und Pneumologische Onkologie
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Version 5.0. / 14.10.2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.